June 02, 2014
Wellesley, Mass., June 2, 2014 – BCC Research is pleased to announce BCC Research Tarceva® Forecast, a strategic investment product designed to provide critical market data for the pharmaceutical lung cancer drug Tarceva.
Tarceva (Astellas Pharma) is a once-daily, oral, non-chemotherapy prescription drug for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). Some clinical studies have shown superior patient outcomes from use of Tarceva as a second-line treatment for NSCLC. Starting in 2020, Tarceva begins to lose patent protection in numerous countries.
Through Tarceva® Forecast, BCC Research provides high-quality intelligence for strategic decision-making regarding future participation in this large and important market. Market players can use Tarceva® Forecast to examine forecasted market demand for Tarceva, identify new business and investment opportunities for related products and services, and validate other Tarceva market-demand data.
Tarceva® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters, featuring market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume and value. Data transparency and sources are disclosed for patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence, as well as for population estimates at the country level, product pricing and currency valuation forecasts. In addition, it breaks down the market for the following regions: Africa/Oceana, United States, Japan, Europe, Latin America, China, Asia, and the Middle East.
About BCC Research
BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years we've helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key competitors. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Our clients include the top companies in industries around the world as well as universities, business schools, start-ups, consulting firms and investment companies. BCC Research is a unit of Eli Research LLC. Visit our website at www.bccresearch.com. Contact us: (+1) 781-489-7301 (U.S. Eastern time), or email information@bccresearch.com.
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49-2 Walnut Park, Wellesley, MA 02481, Telephone: (+1) 781-489-7301; Email: editor@bccresearch.com as the source and publisher. Thank you.
BCC Research Tarceva ® Forecast( FMO001A )
Publish Date: May 2014
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.